KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $700000.0.

  • West Pharmaceutical Services' Amortizatization of Intangibles fell 2222.22% to $700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 2250.0%. This contributed to the annual value of $3.6 million for FY2024, which is 0.0% changed from last year.
  • Per West Pharmaceutical Services' latest filing, its Amortizatization of Intangibles stood at $700000.0 for Q3 2025, which was down 2222.22% from $600000.0 recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Amortizatization of Intangibles high stood at $2.1 million for Q4 2021, and its period low was $500000.0 during Q2 2023.
  • In the last 5 years, West Pharmaceutical Services' Amortizatization of Intangibles had a median value of $900000.0 in 2022 and averaged $973684.2.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 9090.91% in 2021, then tumbled by 5238.1% in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Amortizatization of Intangibles (Quarter) stood at $2.1 million in 2021, then crashed by 52.38% to $1.0 million in 2022, then rose by 30.0% to $1.3 million in 2023, then plummeted by 30.77% to $900000.0 in 2024, then fell by 22.22% to $700000.0 in 2025.
  • Its last three reported values are $700000.0 in Q3 2025, $600000.0 for Q2 2025, and $900000.0 during Q1 2025.